市場調査レポート

血管アクセスサイト閉塞デバイスの世界市場

International Markets for Vascular Access Site Closure Devices

発行 Medtech Insight 商品コード 309480
出版日 ページ情報 英文 179 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
血管アクセスサイト閉塞デバイスの世界市場 International Markets for Vascular Access Site Closure Devices
出版日: 2014年07月01日 ページ情報: 英文 179 Pages
概要

米国では34秒に1人が冠動脈イベントを経験し、また83秒に1人がそのようなイベントで亡くなっています。現在、米国では20歳以上の成人の1,540万人が冠動脈性心疾患を、850万人が末梢動脈疾患を患っています。高齢者セグメントにおける冠動脈・末梢血管疾患の患者数、および心疾患、糖尿病および肥満といった慢性疾患の患者数は、今後も増加する見込みです。2013年において、世界の心血管・末梢血管疾患向けアクセスサイト管理デバイス市場の収益は、約9億2,370万米ドルとなりました。同収益は2018年に12億米ドルになると予測されています。

当レポートでは、世界の血管アクセスサイト管理デバイス市場について調査し、製品、現在・新興の市場、競合企業およびサプライヤーにとっての機会などを分析しており、地域・主要国別の市場予測などをまとめ、お届けいたします。

エグゼクティブサマリー

第1章 心血管疾患の概要

  • 心臓・循環系
  • 主な心疾患/障害
    • 冠動脈性心疾患
    • 高血圧
    • 心筋症
    • 先天性心臓欠陥
    • 心不全
  • 末梢血管疾患の概要
  • 循環系の構造・生理機能
  • 末梢血管疾患の種類
    • 末梢動脈疾患
    • 動脈瘤
    • 深部静脈血栓症・肺塞栓症
    • 慢性静脈不全

第2章 血管アクセスサイト閉塞デバイス

  • 技術
  • 合併症
  • 製品

第3章 世界の血管アクセスサイト管理デバイス市場予測

  • 競合企業
  • 市場予測:北米
    • 競合企業
    • 市場予測:米国
    • 市場予測:カナダ
  • 市場予測:欧州
    • 競合企業
    • 市場予測:フランス
    • 市場予測:ドイツ
    • 市場予測:イタリア
    • 市場予測:スペイン
    • 市場予測:英国
  • 市場予測:アジア太平洋地域
    • 競合企業
    • 市場予測:中国
    • 市場予測:インド
    • 市場予測:日本
    • 市場予測:韓国
    • 市場予測:台湾
  • 市場予測:アフリカ・中東
  • 市場予測:中南米
    • 競合企業
    • 市場予測:ブラジル
    • 市場予測:アルゼンチン
    • 市場予測:メキシコ

付録

目次
Product Code: A203

Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have coronary and peripheral vascular disease is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from coronary heart disease and 8.5 million adults age 20 or older in the U.S. have peripheral artery disease.

Interventional management of cardiovascular and peripheral vascular diseases via transcatheter techniques requires vascular access site management systems in order to prevent bleeding and the formation of hematoma following introducer/sheath removal. Vascular access site closure devices have evolved beyond simple manual compression devices since their initial introduction in 1995 by Datascope (now part of Maquet Holding). However, manual compression remains the gold standard despite limitations to its use, including the need for the patient to be undergoing anticoagulation therapy or have undergone an endovascular intervention with a large access site. In 2013, vascular access site management devices for cardiovascular and peripheral indications generated approximately $923.7 million internationally in corresponding product sales; it is expected that, in the year 2018, these methods will generate an estimated $1.2 billion in corresponding product sales.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of vascular access site management devices to international markets. Regions covered in this report include North America, Europe, Asia-Pacific, Africa and the Middle East, and Central and South America. Select countries and the vascular access site management systems markets from these regions are analyzed in depth.

Table of Contents

EXECUTIVE SUMMARY

  • i. Global Market Forecast For Vascular Access Site Management Devices
    • a. North America
    • b. Europe
    • c. Asia-Pacific
    • d. Africa and the Middle East
    • e. Central and South America
  • ii. Methodology
  • Exhibit ES-1: Global Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit ES-2: 2013, Global Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-3: 2013, North American Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-4: 2013, European Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-5: 2013, Asia-Pacific Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-6: 2013, African and Middle Eastern Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit ES-7: 2013, Central and South American Vascular Access Site Closure Systems, Share by Supplier

1. CARDIOVASCULAR DISEASE OVERVIEW

  • 1.1 The Heart and Circulatory System
  • 1.2 Selected Heart Diseases/Disorders
    • 1.2.1 Coronary Heart Disease
      • 1.2.1.1 Atherosclerosis
      • 1.2.1.2 Angina Pectoris
      • 1.2.1.3 Myocardial Infarction
    • 1.2.2 Hypertension
      • 1.2.2.1 Systolic and Diastolic Pressures
      • 1.2.2.2 Prehypertension
    • 1.2.3 Cardiomyopathy
      • 1.2.3.1 Dilated Cardiomyopathy
      • 1.2.3.2 Hypertrophic Cardiomyopathy
      • 1.2.3.3 Restrictive Cardiomyopathy
    • 1.2.4 Congenital Heart Defects
      • 1.2.4.1 Ventricular Septal Defects
      • 1.2.4.2 Atrial Septal Defects
      • 1.2.4.3 Patent Ductus Arteriosus
    • 1.2.5 Heart Failure
      • 1.2.5.1 Disease Development
      • 1.2.5.2 Ejection Fraction Reduction
      • 1.2.5.3 Classification/Staging Systems
  • 1.3 Peripheral Vascular Disease Overview
  • 1.4 Anatomy and Physiology of the Circulatory System
  • 1.5 Types of Peripheral Vascular Disease
    • 1.5.1 Peripheral Artery Disease
      • 1.5.1.1 Etiology
      • 1.5.1.2 Epidemiology
    • 1.5.2 Aneurysm
      • 1.5.2.1 Etiology
      • 1.5.2.2 Epidemiology
    • 1.5.3 Deep Vein Thrombosis and Pulmonary Embolism
      • 1.5.3.1 Etiology
      • 1.5.3.2 Epidemiology
    • 1.5.4 Chronic Venous Insufficiency
      • 1.5.4.1 Etiology
      • 1.5.4.2 Epidemiology
  • Exhibit 1-1: Cross-Section Diagram of the Heart
  • Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors
  • Exhibit 1-3: Standard Angina Pectoris Classification
  • Exhibit 1-4: Angina Pectoris, Selected Statistics
  • Exhibit 1-5: Clinical Classification of AMI
  • Exhibit 1-6: Myocardial Infarction, Selected Statistics
  • Exhibit 1-7: Percentage of Adults Diagnosed With High Blood Pressure, by State
  • Exhibit 1-8: Hypertension, Selected Statistics
  • Exhibit 1-9: Cardiomyopathy, Selected Statistics
  • Exhibit 1-10: Congenital Heart Defects, Selected Statistics
  • Exhibit 1-11: Summary, New York Heart Association Heart Failure Classification System
  • Exhibit 1-12: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System
  • Exhibit 1-13: Heart Failure, Selected Statistics
  • Exhibit 1-14: Peripheral Artery Disease, Selected Statistics
  • Exhibit 1-15: Aortic Aneurysm, Selected Statistics
  • Exhibit 1-16: Deep Vein Thrombosis, Selected Statistics
  • Exhibit 1-17: Classification of Chronic Venous Insuffiency
  • Exhibit 1-18: Chronic Venous Insufficiency, Selected Statistics

2. VASCULAR ACCESS SITE CLOSURE DEVICES

  • 2.1 Technologies
  • 2.2 Complications
  • 2.3 Products
  • Exhibit 2-1: 2014, Selected Vascular Access Site Closure Devices

3. GLOBAL MARKET FORECAST FOR VASCULAR ACCESS SITE MANAGEMENT DEVICES

  • 3.1 Competitors
  • 3.2 Market Forecast: North America
    • 3.2.1 Competitors
    • 3.2.2 Market Forecast By Selected Countries: United States
      • 3.2.2.1 Competitors
    • 3.2.3 Market Forecast By Selected Countries: Canada
      • 3.2.3.1 Competitors
  • 3.3 Market Forecast: Europe
    • 3.3.1 Competitors
    • 3.3.2 Market Forecast By Selected Countries: France
      • 3.3.2.1 Competitors
    • 3.3.3 Market Forecast By Selected Countries: Germany
      • 3.3.3.1 Competitors
    • 3.3.4 Market Forecast By Selected Countries: Italy
      • 3.3.4.1 Competitors
    • 3.3.5 Market Forecast By Selected Countries: Spain
      • 3.3.5.1 Competitors
    • 3.3.6 Market Forecast By Selected Countries: United Kingdom
      • 3.3.6.1 Competitors
  • 3.4 Market Forecast: Asia-Pacific
    • 3.4.1 Competitors
    • 3.4.2 Market Forecast By Selected Countries: China
      • 3.4.2.1 Competitors
    • 3.4.3 Market Forecast By Selected Countries: India
      • 3.4.3.1 Competitors
    • 3.4.4 Market Forecast By Selected Countries: Japan
      • 3.4.4.1 Competitors
    • 3.4.5 Market Forecast By Selected Countries: South Korea
      • 3.4.5.1 Competitors
    • 3.4.6 Market Forecast By Selected Countries: Taiwan
      • 3.4.6.1 Competitors
  • 3.5 Market Forecast: Africa and the Middle East
    • 3.5.1 Competitors
  • 3.6 Market Forecast: Central and South America
    • 3.6.1 Competitors
    • 3.6.2 Market Forecast By Selected Countries: Brazil
      • 3.6.2.1 Competitors
    • 3.6.3 Market Forecast By Selected Countries: Argentina
      • 3.6.3.1 Competitors
    • 3.6.4 Market Forecast By Selected Countries: Mexico
      • 3.6.4.1 Competitors
  • Exhibit 3-1: Global Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-2: 2013, Global Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-3: North American Vascular Access Site Closure Device, Market Forecast, 2013-2018
  • Exhibit 3-4: 2013, North American Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-5: United States Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-6: 2013, United States Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-7: Canadian Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-8: 2013, Canadian Vascular Access Site Closure Systems, Share By Supplier
  • Exhibit 3-9: European Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-10: Vascular Access Site Closure System Sales For Select European Countries, Combined Market Forecast, 2013-2018
  • Exhibit 3-11: 2013, European Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-12: 2013, French Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-13: 2013, German Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-14: 2013, Italian Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-15: 2013, Spanish Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-16: 2013, United Kingdom Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-17: Asia-Pacific Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-18: Vascular Access Site Closure System Sales For Select Asia-Pacific Countries ,Combined Market Forecast, 2013-2018
  • Exhibit 3-19: 2013, Asia-Pacific Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-20: 2013, Chinese Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-21: 2013, Indian Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-22: 2013, Japanese Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-23: 2013, South Korean Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-24: 2013, Taiwanese Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-25: African and Middle Eastern Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-26: 2013, African and Middle Eastern Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-27: Central and South America Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-28: Vascular Access Site Closure System Sales For Select Central and South American Countries, Combined Market Forecast, 2013-2018
  • Exhibit 3-29: 2013, Central and South American Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-30: 2013, Brazilian Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-31: 2013, Argentinean Vascular Access Site Closure Systems, Share by Supplier
  • Exhibit 3-32: 2013, Mexican Vascular Access Site Closure Systems, Share by Supplier

APPENDIX: COMPANY LISTING

Back to Top